SCHEMBL3722157

SCHEMBL3722157

CC(C)c1[nH]nc2c(NCc3cc(F)ccc3O)nc(NCC(O)CN)nc12

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 19/20 0.57
CCNE1 P24864 18/20 0.57
CDK5 Q00535 12/20 0.49
CDK9 P50750 6/20 0.47
CDK7 P50613 3/20 0.47
CDK1 P06493 3/20 0.47
CCNE2 O96020 2/20 0.45
AURKA O14965 1/20 0.45
CCNT1 O60563 5/20 0.45
CDK5R1 Q15078 4/20 0.45
CCNH P51946 2/20 0.45
CCNB1 P14635 2/20 0.44
CCNB2 O95067 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
CCNT2 O60583 1/20 0.41
CDK4 P11802 1/20 0.41
CCNA2 P20248 1/20 0.41
CCND1 P24385 1/20 0.41
CDK6 Q00534 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718690 0.86 CDK2 (0.51) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3720099 0.85 CDK2 (0.56) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3722170 0.85 CCNE1 (0.44) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3720115 0.85 CDK2 (0.51) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3721972 0.82 CDK2 (0.60) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3719276 0.80 CDK2 (0.68) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3724859 0.79 CDK2 (0.69) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3794926 0.78 CDK2 (0.52) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL3724482 0.76 CDK2 (0.51) CDK2CCNE1CDK5CDK9CDK7
SCHEMBL7259669 0.75 CDK2 (0.55) CDK2CCNE1CDK5CDK9CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010139288-A1 5,7-DISUBSTITUTED 3-ISOPROPYLPYRAZOLO[4,3-D]PYRIMIDINES FOR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS C3 BIO GMBH (DE) 2010-12-09 WO disclosed